HPGD Antikörper

Produktnummer ABIN540849

Produktdetails anti-HPGD Antikörper

Target: HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser HPGD Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF)

Verwendungszweck: Rabbit polyclonal antibody raised against HPGD.

Spezifität: This antibody is specific to 15-PGDH.

Kreuzreaktivität: Human

Produktmerkmale: Antibody Reactive Against HPGD.

Immunogen: Human HPGD.

Anwendungsinformationen

Applikationshinweise: Western Blot (1:5000-1:6000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In Tris-glycine, 150 mM NaCl (0.05 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for short term. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-HPGD Antikörper (ABIN540849)

Mann, Backlund, Buchanan, Daikoku, Holla, Rosenberg, Dey, DuBois: "Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression." in: Cancer research, Vol. 66, Issue 13, pp. 6649-56, (2006) (PubMed).

Backlund, Mann, Holla, Buchanan, Tai, Musiek, Milne, Katkuri, DuBois: "15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer." in: The Journal of biological chemistry, Vol. 280, Issue 5, pp. 3217-23, (2005) (PubMed).

Ding, Tong, Liu, Moscow, Tai: "NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer." in: Carcinogenesis, Vol. 26, Issue 1, pp. 65-72, (2004) (PubMed).

Yan, Rerko, Platzer, Dawson, Willis, Tong, Lawrence, Lutterbaugh, Lu, Willson, Luo, Hensold, Tai, Wilson, Markowitz: "15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 50, pp. 17468-73, (2004) (PubMed).

Giannoulias, Patel, Holloway, Lye, Tai, Challis: "Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium." in: The Journal of clinical endocrinology and metabolism, Vol. 87, Issue 3, pp. 1345-52, (2002) (PubMed).

Details zu HPGD

Target: HPGD (Hydroxyprostaglandin Dehydrogenase 15-(NAD) (HPGD))

Andere Bezeichnung: HPGD (HPGD Produkte)

Synonyme: CBR antikoerper, SDR21C1 antikoerper, hCBR1 antikoerper, 15-PGDH antikoerper, PGDH antikoerper, PGDH1 antikoerper, PHOAR1 antikoerper, SDR36C1 antikoerper, MGC80546 antikoerper, MGC79454 antikoerper, AV026552 antikoerper, carbonyl reductase 1 antikoerper, 15-hydroxyprostaglandin dehydrogenase antikoerper, hydroxyprostaglandin dehydrogenase 15-(NAD) antikoerper, 15-hydroxyprostaglandin dehydrogenase L homeolog antikoerper, hydroxyprostaglandin dehydrogenase 15 (NAD) antikoerper, CBR1 antikoerper, HPGD antikoerper, hpgd.L antikoerper, hpgd antikoerper, pgdh antikoerper, Hpgd antikoerper, PTRG_03214 antikoerper, VDBG_09957 antikoerper

Gen-ID: 3248